The Baldwin Insurance Group, Inc.Q2 results show strong growth and higher EBITDA but wider net loss; valuation debate with targets ranging $23-$40 and stock trading above industry P/S.

Baldwin Insurance Group posted second-quarter 2026 results featuring strong top-line growth and higher adjusted EBITDA alongside a wider net loss and a renewed focus on efficiency and integration. The most-followed analyst narrative pegs fair value at $29.33, about 5.4% above the last close of $27.74, though price targets range from $23.00 to $40.00. On a price-to-sales basis, the stock trades at roughly 1.5 times sales versus the US insurance industry average of 1.2 times and a fair ratio of 1.0 times, pointing to valuation risk if growth or margins disappoint. The shares have returned 25.92% over the past 90 days and 16.65% year to date, even as the one-year total shareholder return shows a decline of 21.44%.
The Baldwin Insurance Group, Inc.Q2 results show strong growth and higher EBITDA but wider net loss; valuation debate with targets ranging $23-$40 and stock trading above industry P/S.